David Hale - Director, Oncternal Therapeutics, Inc

As of July 2, 2021


David Hale Net Worth

  • Net worth is estimated to be at least $4.59M
  • Owns at least 731,498 units of Oncternal Therapeutics, Inc stock
  • Sold an estimated value of $17.43K in the last 2 years at Oncternal Therapeutics, Inc

David Hale Trading

  • Largest sale of shares was 3,669 units , worth over $17.43K on July 2, 2021
  • In total has made about 6 transactions over 2 years
  • Usually trades in May and June, with the busiest year in 2019, 2020 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

David Hale Mailing Address

  • Mailing address is 1042-B North el Camino Real, Suite 430 Encinitas CA 92024 CA

Oncternal Therapeutics, Inc Insider Trading

  • The most recent transaction was 3,669 units sold on July 2, 2021 by David Hale worth over $17.43K
  • In the last year, insiders at Oncternal Therapeutics, Inc sold an estimated value of $17.43K and bought an estimated value of $2.78M
  • The most active traders are James Breitmeyer, Chief Executive Officer,  David Hale, Director,  and Charles Theuer, Director
  • Insider trading is most common in June, with the busiest year in 2019

Oncternal Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1